The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and ...

Researchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.

IVMED-85 is a preservative-free, non-atropine daily drop that slows myopia progression by strengthening scleral and corneal ...

At ASCO, researchers presented results of Phase I trials evaluating combinations of KRAS G12C inhibitors, EGFR inhibitors, and chemotherapy in colorectal cancer.

Bayer’s Vividion Therapeutics has secured the global rights from its partner Roche to the only Werner helicase (WRN) ...

When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the ...

DeepSeek-R1’s standout feature is its ability to decompose complex problems using chain-of-thought (CoT) reasoning, ...